{
    "code": "01005875",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01005875",
    "time": "2020-02-25 01:53:11",
    "許可證字號": "衛署藥製字第005875號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/02\/18",
    "發證日期": "64\/02\/18",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "鹽酸配西汀",
    "英文品名": "PETHIDINE HYDROCHLORIDE",
    "適應症": "鎮痛劑",
    "劑型": "040（粉）",
    "包裝": "１公克以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產 1P原料藥未取得PIC\/S GMP核准函 不得製造 32第二級管制藥品",
        "申請商名稱": "0603401200  衛生福利部食品藥物管理署管制藥品製藥工廠",
        "申請商地址": "新北市三峽區大同路２８７號",
        "主製造廠": ""
    },
    "CCC號列": "29333300009 阿華吩坦尼（ＩＮＮ）、安尼勒立汀（ＩＮＮ）、培集屈密特（ＩＮＮ）、溴西泮（ＩＮＮ）、狄芬諾新（ＩＮＮ）、狄芬諾西萊（ＩＮＮ）、狄匹潘濃（ＩＮＮ）、吩坦尼（ＩＮＮ）、酚派丙酮（ＩＮＮ）、派醋甲酯（ＩＮＮ）、潘他唑新（ＩＮＮ）、配西汀（ＩＮＮ）、配西汀（ＩＮＮ）中間體、苯環利定（ＩＮＮ）（ＰＣＰ）、吩諾配立汀（ＩＮＮ）、派苯甲醇（ＩＮＮ）、匹立屈密特（ＩＮＮ）、普魯匹蘭（ＩＮＮ）及屈美配立汀（ＩＮＮ）；其鹽類Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate a, phencyclidine (INN) (pcp), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808800510",
            "成分名稱": "MEPERIDINE HCL ( EQ TO PETHIDINE HYDROCHLORIDE )",
            "含量描述": "",
            "含量": "",
            "單位": ""
        }
    ]
}